Skip to contentRA Capital Nexus Fund, L.P. — Tyra Biosciences, Inc. insider: 21 transactions · InsiderLensRA Capital Nexus Fund, L.P.
- Director at Icosavax, Inc. · on record since Jun 8, 2023
- 10% owner at Icosavax, Inc. · on record since Jun 8, 2023
- Director at Black Diamond Therapeutics, Inc. · on record since Jul 7, 2023
- Director at Vor Biopharma Inc. · on record since May 28, 2024
- 10% owner at Vor Biopharma Inc. · on record since May 28, 2024
- Director at Sionna Therapeutics, Inc. · on record since Feb 10, 2025
- Director at Climb Bio, Inc. · on record since Apr 29, 2026
- Director at Artiva Biotherapeutics, Inc. · on record since May 13, 2026
- Director at Tyra Biosciences, Inc. · on record since Jun 1, 2026
- Director at Nkarta, Inc. · on record since Jun 11, 2026
- 10% owner at Akouos, Inc. · on record since Jun 25, 2020
- Director at Jade Biosciences, Inc. · on record since Jun 29, 2021
- 10% owner at Tyra Biosciences, Inc. · on record since Sep 17, 2021
- 10% owner at Climb Bio, Inc. · on record since Aug 16, 2021
- 10% owner at Nkarta, Inc. · on record since Apr 28, 2022
- 10% owner at Jade Biosciences, Inc. · on record since Jun 22, 2022
- Director at 89bio, Inc. · on record since Jun 2, 2022
- 10% owner at 89bio, Inc. · on record since Jun 2, 2022
- Director at Solid Biosciences Inc. · on record since Dec 15, 2022
- 10% owner at Solid Biosciences Inc. · on record since Dec 15, 2022
Insider trading activity of RA Capital Nexus Fund, L.P.
- Transactions on record
- 21
- since Sep 17, 2021
- Open-market buys
- 4
- $44M
- Open-market sells
- 5
- $3.4M
- Companies traded
- 5
- last filing Oct 22, 2025
Figures computed from official regulatory filings — methodology.
Companies where RA Capital Nexus Fund, L.P. has traded
Track record of RA Capital Nexus Fund, L.P.
Statistical track record
Free- Open-market buys
- 5
- Last buy
- Jan 11, 2024
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of RA Capital Nexus Fund, L.P.
Co-insiders of RA Capital Nexus Fund, L.P.
- Kolchinsky Peter89bio, Inc. +11
- RA Capital Biotech Fund LP89bio, Inc. +11
- RA CAPITAL MANAGEMENT, LLC89bio, Inc. +11
- Shah Rajeev M.89bio, Inc. +11
- Chen BihuaAkouos, Inc. +3
- Cormorant Asset Management, LPAkouos, Inc. +3
- Cormorant Global Healthcare Master Fund, LPAkouos, Inc. +3
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
BASKETT FORESTAkouos, Inc. +2
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Oct 22, 2025 | Sell | -6,553 | 30.12 USD | $197.4K | SEC |
| Oct 22, 2025 | Sell | -1,287 | 30.12 USD | $38.8K | SEC |
| Oct 22, 2025 | Sell | -25,027 | 28.11 USD | $703.5K | SEC |
| Oct 22, 2025 | Sell | -13,817 | 29.63 USD | $409.4K | SEC |
| Oct 22, 2025 | Sell | -70,366 | 29.63 USD | $2.1M | SEC |
| Jun 7, 2024 | AwardD | 12,500 | 0.00 USD | $0 | SEC |
| Jan 12, 2024 | Buy | 904,160 | 5.53 USD | $5M | SEC |
| Jun 2, 2023 | AwardD | 14,500 | 0.00 USD | $0 | SEC |
| Dec 15, 2022 | AwardD | 9,650 | 0.00 USD | $0 | SEC |
| Oct 20, 2022 | Buy | 1,172,741 | 7.65 USD | $9M | SEC |
| Jul 6, 2022 | BuyD | 2,816,900 | 0.00 USD | $0 | SEC |
| Jul 6, 2022 | Buy | 2,816,900 | 3.55 USD | $10M | SEC |
| Sep 17, 2021 | Other | 1,496,613 | — | — | SEC |
| Sep 17, 2021 | OtherD | -182,257 | 0.00 USD | $0 | SEC |
| Sep 17, 2021 | OtherD | -170,448 | 0.00 USD | $0 | SEC |
| Sep 17, 2021 | OtherD | -393,940 | 0.00 USD | $0 | SEC |
| Sep 17, 2021 | OtherD | -1,011,370 | 0.00 USD | $0 | SEC |
| Sep 17, 2021 | Other | 4,047,120 | — | — | SEC |
| Sep 17, 2021 | Other | 442,721 | — | — | SEC |
| Sep 17, 2021 | OtherD | -546,773 | 0.00 USD | $0 | SEC |
| Sep 17, 2021 | Buy | 1,250,000 | 16.00 USD | $20M | SEC |